These thirty remarkable discoveries from 2024-2025 represent only a fraction of the archaeological treasures emerging from soil, sand, and sea around the world. Each find adds another piece to the ...
Acquisition adds complementary asset to the Pelthos commercial portfolioXeglyze is a novel, FDA-approved prescription ...
Acquisition adds complementary asset to the Pelthos commercial portfolioXeglyze is a novel, FDA-approved prescription medication indicated for the topical treatment of head lice infestation in patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback